Opioids: a two-faced Janus

References

• Breivik H, Collett B, Ventafridda V, et al. Survey of chronic pain in Europe: prevalence, impact on daily life, and treatment. Eur J Pain 2006;10:287-333
   PubMed Web of Science ®Google Scholar
• Silvemark AJ, Kallmen H, Portala K, et al. Life satisfaction in patients with long-term non-malignant pain – relating LiSat-11 to the Multidimensional Pain Inventory (MPI). Health Qual Life Outcomes 2008;6:70
   PubMed Web of Science ®Google Scholar
• Blyth FM, March LM, Brnabic AJ, et al. Chronic pain and frequent use of health care. Pain 2004;111:51-8
   PubMed Web of Science ®Google Scholar
• International Association for the Study of Pain, European Federation of IASP Chapters. Unrelieved pain is a major global healthcare problem (IASP EFIC Factsheet 4A). 2005. Available at: http://www.iasp-pain.org/AM/Template.cfm?Section=Home&section=2004_2005_Right_to_Pain_Relief&template=/CM/ContentDisplay.cfm&ContentFileID=311 [Last accessed 15 October 2010]
   Google Scholar
• Gardea MA, Gatchel RJ. Interdisciplinary treatment of chronic pain. Curr Rev Pain 2000;4:18-23
   PubMedGoogle Scholar
• Gatchel RJ, Polatin PB, Noe C, et al. Treatment- and cost-effectiveness of early intervention for acute low-back pain patients: a one-year prospective study. J Occup Rehabil 2003;13:1-9
   PubMed Web of Science ®Google Scholar
• Ballantyne JC, Mao J. Opioid therapy for chronic pain. N Engl J Med 2003;349:1943-53
   PubMed Web of Science ®Google Scholar
• Hall EJ, Sykes NP. Analgesia for patients with advanced disease: I. Postgrad Med J 2004;80:148-54
   PubMed Web of Science ®Google Scholar
• McNicol E, Horowicz-Mehler N, Fisk RA, et al. Management of opioid side effects in cancer-related and chronic noncancer pain: a systematic review. J Pain 2003;4:231-56
   PubMed Web of Science ®Google Scholar
• Collett BJ. Opioid tolerance: the clinical perspective. Br J Anaesth 1998;81:58-68
   PubMed Web of Science ®Google Scholar
• Baron R. Neuropathic pain: a clinical perspective. Handb Exp Pharmacol 2009:3-30
   PubMedGoogle Scholar
• Kalso E, Edwards JE, Moore RA, et al. Opioids in chronic non-cancer pain: systematic review of efficacy and safety. Pain 2004;112:372-80
   PubMed Web of Science ®Google Scholar
• Moore RA, McQuay HJ. Prevalence of opioid adverse events in chronic non-malignant pain: systematic review of randomised trials of oral opioids. Arthritis Res Ther 2005;7:R1046-51
   PubMed Web of Science ®Google Scholar
• Ollat H, Cesaro P. Pharmacology of neuropathic pain. Clin Neuropharmacol 1995;18:391-404
   PubMed Web of Science ®Google Scholar
• Turk DC. Clinicians’ attitudes about prolonged use of opioids and the issue of patient heterogeneity. J Pain Symptom Manag 1996;11:218-30
   PubMed Web of Science ®Google Scholar
• World Health Organization. Achieving Balance in National Opioids Control Policy. Guidelines for Assessment. 2000. Available at: http://www.painpolicy.wisc.edu/publicat/00whoabi/00whoabi.htm [Last accessed 15 October 2010]
   Google Scholar
• Chou R, Clark E, Helfand M. Comparative efficacy and safety of long-acting oral opioids for chronic non-cancer pain: a systematic review. J Pain Symptom Manag 2003;26:1026-48
   PubMed Web of Science ®Google Scholar
• Noble M, Tregear SJ, Treadwell JR, et al. Long-term opioid therapy for chronic noncancer pain: a systematic review and meta-analysis of efficacy and safety. J Pain Symptom Manag 2008;35:214-28
   PubMed Web of Science ®Google Scholar
• Rosenblum A, Marsch LA, Joseph H, et al. Opioids and the treatment of chronic pain: controversies, current status, and future directions. Exp Clin Psychopharmacol 2008;16:405-16
   PubMed Web of Science ®Google Scholar
• Pergolizzi J, Boger RH, Budd K, et al. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone). Pain Pract 2008;8:287-313
   PubMedGoogle Scholar
• American Geriatrics Society. Pharmacological management of persistent pain in older persons. J Am Geriatr Soc 2009;57:1331-46
   PubMed Web of Science ®Google Scholar
• Heins A, Grammas M, Heins JK, et al. Determinants of variation in analgesic and opioid prescribing practice in an emergency department. J Opioid Manag 2006;2:335-40
   PubMedGoogle Scholar
• Victor TW, Alvarez NA, Gould E. Opioid prescribing practices in chronic pain management: guidelines do not sufficiently influence clinical practice. J Pain 2009;10:1051-7
   PubMed Web of Science ®Google Scholar
• Reid CM, Martin RM, Sterne JA, et al. Oxycodone for cancer-related pain: meta-analysis of randomized controlled trials. Arch Intern Med 2006;166:837-43
   PubMed Web of Science ®Google Scholar
• Wiffen PJ, McQuay HJ. Oral morphine for cancer pain. Cochrane Database Syst Rev 2007:CD003868
   Google Scholar
• Treede RD, Jensen TS, Campbell JN, et al. Neuropathic pain: redefinition and a grading system for clinical and research purposes. Neurology 2008;70:1630-5
   PubMed Web of Science ®Google Scholar
• Chapman CR, Tuckett RP, Song CW. Pain and stress in a systems perspective: reciprocal neural, endocrine, and immune interactions. J Pain 2008;9:122-45
   PubMed Web of Science ®Google Scholar
• Schmidt CO, Schweikert B, Wenig CM, et al. Modelling the prevalence and cost of back pain with neuropathic components in the general population. Eur J Pain 2009;13:1030-5
   PubMed Web of Science ®Google Scholar
• Picavet HS, Vlaeyen JW, Schouten JS. Pain catastrophizing and kinesiophobia: predictors of chronic low back pain. Am J Epidemiol 2002;156:1028-34
   PubMed Web of Science ®Google Scholar
• van Middendorp H, Lumley MA, Jacobs JW, et al. The effects of anger and sadness on clinical pain reports and experimentally-induced pain thresholds in women with and without fibromyalgia. Arthritis Care Res (Hoboken) 2010;62:1370-6
   PubMed Web of Science ®Google Scholar
• Chen Y, Mestek A, Liu J, et al. Molecular cloning and functional expression of a mu-opioid receptor from rat brain. Mol Pharmacol 1993;44:8-12
   PubMed Web of Science ®Google Scholar
• Martin WR, Eades CG, Thompson JA, et al. The effects of morphine- and nalorphine-like drugs in the nondependent and morphine-dependent chronic spinal dog. J Pharmacol Exp Ther 1976;197:517-32
   PubMed Web of Science ®Google Scholar
• Nicholson B. Responsible prescribing of opioids for the management of chronic pain. Drugs 2003;63:17-32
   PubMed Web of Science ®Google Scholar
• Mollereau C, Mouledous L. Tissue distribution of the opioid receptor-like (ORL1) receptor. Peptides 2000;21:907-17
   PubMed Web of Science ®Google Scholar
• Gutstein H, Akil H. Opioid analgesics. In: Brunton L, Lazo J, Parker K (eds). Goodman & Gilman’s The Pharmacological Basis of Therapeutics, 11th edn. New York: McGraw-Hill, 2006:547-90
   Google Scholar
• Law PY, Wong YH, Loh HH. Molecular mechanisms and regulation of opioid receptor signaling. Annu Rev Pharmacol Toxicol 2000;40:389-430
   PubMedGoogle Scholar
• Lomberk G, Cruciani R, Urrutia R. Primers on molecular pathways – pain and opioid receptors, I. Pancreatology 2008;8:544-5
   PubMed Web of Science ®Google Scholar
• Sweetman S. Martindale. The Complete Drug Reference, 36th edn. London: Pharmaceutical Press, 2009
   Google Scholar
• Corbett AD, Henderson G, McKnight AT, et al. 75 years of opioid research: the exciting but vain quest for the Holy Grail. Br J Pharmacol 2006;147(Suppl. 1):S153-62
   Google Scholar
• Argoff CE, Silvershein DI. A comparison of long- and short-acting opioids for the treatment of chronic noncancer pain: tailoring therapy to meet patient needs. Mayo Clin Proc 2009;84:602-12
   PubMed Web of Science ®Google Scholar
• Vella-Brincat J, Macleod AD. Adverse effects of opioids on the central nervous systems of palliative care patients. J Pain Palliat Care Pharmacother 2007;21:15-25
   PubMedGoogle Scholar
• Kurz A, Sessler DI. Opioid-induced bowel dysfunction: pathophysiology and potential new therapies. Drugs 2003;63:649-71
   PubMed Web of Science ®Google Scholar
• Herndon CM, Jackson KC 2nd, Hallin PA. Management of opioid-induced gastrointestinal effects in patients receiving palliative care. Pharmacotherapy 2002;22:240-50
   PubMed Web of Science ®Google Scholar
• Harris JD. Management of expected and unexpected opioid-related side effects. Clin J Pain 2008;24(Suppl. 10):S8-S13
   PubMed Web of Science ®Google Scholar
• Mao J, Sung B, Ji RR, Lim G. Neuronal apoptosis associated with morphine tolerance: evidence for an opioid-induced neurotoxic mechanism. J Neurosci 2002;22:7650-61
   PubMed Web of Science ®Google Scholar
• Mercadante S, Ferrera P, Villari P, et al. Hyperalgesia: an emerging iatrogenic syndrome. J Pain Symptom Manag 2003;26:769-75
   PubMed Web of Science ®Google Scholar
• Quigley C. Opioid switching to improve pain relief and drug tolerability. Cochrane Database Syst Rev 2004:CD004847
   Google Scholar
• Blake S, Ruel B, Seamark C, et al. Experiences of patients requiring strong opioid drugs for chronic non-cancer pain: a patient-initiated study. Br J Gen Pract 2007;57:101-8
   PubMed Web of Science ®Google Scholar
• Manchikanti L, Manchikanti KN, Pampati V, et al. Prevalence of side effects of prolonged low or moderate dose opioid therapy with concomitant benzodiazepine and/or antidepressant therapy in chronic non-cancer pain. Pain Physician 2009;12:259-67
   PubMed Web of Science ®Google Scholar
• Portenoy RK, Farrar JT, Backonja MM, et al. Long-term use of controlled-release oxycodone for noncancer pain: results of a 3-year registry study. Clin J Pain 2007;23:287-99
   PubMed Web of Science ®Google Scholar
• Edlund MJ, Steffick D, Hudson T, et al. Risk factors for clinically recognized opioid abuse and dependence among veterans using opioids for chronic non-cancer pain. Pain 2007;129:355-62
   PubMed Web of Science ®Google Scholar
• Ives TJ, Chelminski PR, Hammett-Stabler CA, et al. Predictors of opioid misuse in patients with chronic pain: a prospective cohort study. BMC Health Serv Res 2006;6:46
   PubMed Web of Science ®Google Scholar
• Reid MC, Engles-Horton LL, Weber MB, et al. Use of opioid medications for chronic noncancer pain syndromes in primary care. J Gen Intern Med 2002;17:173-9
   PubMed Web of Science ®Google Scholar
• Gourlay DL, Heit HA, Almahrezi A. Universal precautions in pain medicine: a rational approach to the treatment of chronic pain. Pain Med 2005;6:107-12
   PubMed Web of Science ®Google Scholar
• Passik SD. Issues in long-term opioid therapy: unmet needs, risks, and solutions. Mayo Clin Proc 2009;84:593-601
   PubMed Web of Science ®Google Scholar
• Webster LR, Webster RM. Predicting aberrant behaviors in opioid-treated patients: preliminary validation of the Opioid Risk Tool. Pain Med 2005;6:432-42
   PubMed Web of Science ®Google Scholar
• McCarberg BH, Nicholson BD, Todd KH, et al. The impact of pain on quality of life and the unmet needs of pain management: results from pain sufferers and physicians participating in an Internet survey. Am J Ther 2008;15:312-20
   PubMed Web of Science ®Google Scholar
• Davis MP, Walsh D, Lagman R, et al. Controversies in pharmacotherapy of pain management. Lancet Oncol 2005;6:696-704
   PubMed Web of Science ®Google Scholar
• Gatti A, Sabato AF, Occhioni R, et al. Controlled-release oxycodone and pregabalin in the treatment of neuropathic pain: results of a multicenter Italian study. Eur Neurol 2009;61:129-37
   PubMed Web of Science ®Google Scholar
• Gatti A, Sabato E, Di Paolo AR, et al. Oxycodone/paracetamol: a low-dose synergic combination useful in different types of pain. Clin Drug Investig 2010;30(Suppl. 2):3-14
   PubMed Web of Science ®Google Scholar
• Bell RF, Dahl JB, Moore RA, et al. Perioperative ketamine for acute postoperative pain. Cochrane Database Syst Rev 2006:CD004603
   Google Scholar
• Dauri M, Faria S, Gatti A, et al. Gabapentin and pregabalin for the acute post-operative pain management. A systematic-narrative review of the recent clinical evidences. Curr Drug Targets 2009;10:716-33
   PubMed Web of Science ®Google Scholar
• Geppetti P, Benemei S. Pain treatment with opioids: achieving the minimal effective and the minimal interacting dose. Clin Drug Investig 2009;29(Suppl. 1):3-16
   PubMedGoogle Scholar
• DeHaven-Hudkins DL, DeHaven RN, Little PJ, et al. The involvement of the mu-opioid receptor in gastrointestinal pathophysiology: therapeutic opportunities for antagonism at this receptor. Pharmacol Ther 2008;117:162-87
   PubMed Web of Science ®Google Scholar
• Becker G, Blum HE. Novel opioid antagonists for opioid-induced bowel dysfunction and postoperative ileus. Lancet 2009;373:1198-206
   PubMed Web of Science ®Google Scholar
• Lowenstein O, Leyendecker P, Hopp M, et al. Combined prolonged-release oxycodone and naloxone improves bowel function in patients receiving opioids for moderate-to-severe non-malignant chronic pain: a randomised controlled trial. Expert Opin Pharmacother 2009;10:531-43
   PubMed Web of Science ®Google Scholar
• Nadstawek J, Leyendecker P, Hopp M, et al. Patient assessment of a novel therapeutic approach for the treatment of severe, chronic pain. Int J Clin Pract 2008;62:1159-67
   PubMed Web of Science ®Google Scholar
• Vondrackova D, Leyendecker P, Meissner W, et al. Analgesic efficacy and safety of oxycodone in combination with naloxone as prolonged release tablets in patients with moderate to severe chronic pain. J Pain 2008;9:1144-54
   PubMed Web of Science ®Google Scholar
• Stein C, Lang LJ. Peripheral mechanisms of opioid analgesia. Curr Opin Pharmacol 2009;9:3-8
   PubMed Web of Science ®Google Scholar
• Walker JS. Anti-inflammatory effects of opioids. Adv Exp Med Biol 2003;521:148-60
   PubMed Web of Science ®Google Scholar
• Ahmedzai S, Brooks D. Transdermal fentanyl versus sustained-release oral morphine in cancer pain: preference, efficacy, and quality of life. The TTS-Fentanyl Comparative Trial Group. J Pain Symptom Manag 1997;13:254-61
   PubMed Web of Science ®Google Scholar
• Allan L, Richarz U, Simpson K, et al. Transdermal fentanyl versus sustained release oral morphine in strong-opioid naive patients with chronic low back pain. Spine (Phila Pa 1976) 2005;30:2484-90
   PubMed Web of Science ®Google Scholar
• Donner B, Zenz M, Tryba M, et al. Direct conversion from oral morphine to transdermal fentanyl: a multicenter study in patients with cancer pain. Pain 1996;64:527-34
   PubMed Web of Science ®Google Scholar
• Kress HG. Clinical update on the pharmacology, efficacy and safety of transdermal buprenorphine. Eur J Pain 2009;13:219-30
   PubMed Web of Science ®Google Scholar
• Shipton EA. Safety and tolerability of buprenorphine. In: Budd K, Raffa R (eds). Buprenorphine – The Unique Opioid Analgesic. Stuttgart: Thieme Verlag KG, 2005:92-101
   Google Scholar
• Watkins LR, Hutchinson MR, Rice KC, et al. The ‘toll’ of opioid-induced glial activation: improving the clinical efficacy of opioids by targeting glia. Trends Pharmacol Sci 2009;30:581-91
   PubMed Web of Science ®Google Scholar
• Hutchinson MR, Bland ST, Johnson KW, et al. Opioid-induced glial activation: mechanisms of activation and implications for opioid analgesia, dependence, and reward. Scientific World Journal 2007;7:98-111
   Google Scholar
• Hutchinson MR, Zhang Y, Shridhar M, et al. Evidence that opioids may have toll-like receptor 4 and MD-2 effects. Brain Behav Immun 2010;24:83-95
   PubMed Web of Science ®Google Scholar
• Hameed H, Hameed M, Christo PJ. The effect of morphine on glial cells as a potential therapeutic target for pharmacological development of analgesic drugs. Curr Pain Headache Rep 2010;14:96-104
   PubMed Web of Science ®Google Scholar
• Ledeboer A, Hutchinson MR, Watkins LR, et al. Ibudilast (AV-411). A new class therapeutic candidate for neuropathic pain and opioid withdrawal syndromes. Expert Opin Investig Drugs 2007;16:935-50
   PubMed Web of Science ®Google Scholar
• Oertel BG, Felden L, Tran PV, et al. Selective antagonism of opioid-induced ventilatory depression by an ampakine molecule in humans without loss of opioid analgesia. Clin Pharmacol Ther 2010;87:204-11
   PubMed Web of Science ®Google Scholar
• Dahan A, Aarts L, Smith TW. Incidence, reversal, and prevention of opioid-induced respiratory depression. Anesthesiology 2010;112:226-38
   PubMed Web of Science ®Google Scholar
• Hartrick CT. Tapentadol immediate release for the relief of moderate-to-severe acute pain. Expert Opin Pharmacother 2009;10:2687-96
   PubMed Web of Science ®Google Scholar
• Tzschentke TM, Jahnel U, Kogel B, et al. Tapentadol hydrochloride: A next-generation, centrally acting analgesic with two mechanisms of action in a single molecule. Drugs Today (Barc) 2009;45:483-96
   PubMed Web of Science ®Google Scholar
• Tzschentke TM, Christoph T, Kogel B, et al. (-)-(1R,2R)-3-(3-dimethylamino-1-ethyl-2-methyl-propyl)-phenol hydrochloride (tapentadol HCl): a novel mu-opioid receptor agonist/norepinephrine reuptake inhibitor with broad-spectrum analgesic properties. J Pharmacol Exp Ther 2007;323:265-76
   PubMed Web of Science ®Google Scholar